PT910376E - Utilizacao de clotrimazole e compostos relacionados no tratamento da diarreia - Google Patents

Utilizacao de clotrimazole e compostos relacionados no tratamento da diarreia

Info

Publication number
PT910376E
PT910376E PT97916035T PT97916035T PT910376E PT 910376 E PT910376 E PT 910376E PT 97916035 T PT97916035 T PT 97916035T PT 97916035 T PT97916035 T PT 97916035T PT 910376 E PT910376 E PT 910376E
Authority
PT
Portugal
Prior art keywords
diarrhea
scours
clotrimazole
utilization
treatment
Prior art date
Application number
PT97916035T
Other languages
English (en)
Portuguese (pt)
Inventor
Seth Alper
Carlo Brugnara
Wayne I Lencer
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of PT910376E publication Critical patent/PT910376E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97916035T 1996-03-20 1997-03-20 Utilizacao de clotrimazole e compostos relacionados no tratamento da diarreia PT910376E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/621,169 US5889038A (en) 1996-03-20 1996-03-20 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds

Publications (1)

Publication Number Publication Date
PT910376E true PT910376E (pt) 2003-12-31

Family

ID=24489031

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97916035T PT910376E (pt) 1996-03-20 1997-03-20 Utilizacao de clotrimazole e compostos relacionados no tratamento da diarreia

Country Status (9)

Country Link
US (3) US5889038A (enExample)
EP (1) EP0910376B1 (enExample)
JP (2) JP2000506895A (enExample)
AT (1) ATE245981T1 (enExample)
DE (1) DE69723843T2 (enExample)
DK (1) DK0910376T3 (enExample)
ES (1) ES2199358T3 (enExample)
PT (1) PT910376E (enExample)
WO (1) WO1997034599A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034589A1 (en) 1996-03-20 1997-09-25 President And Fellows Of Harvard College Triaryl methane compounds for sickle cell disease
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
US6667063B2 (en) * 1998-06-10 2003-12-23 Albert Crum Nutritional or therapeutic supplement and method
DE60322019D1 (de) * 2002-01-04 2008-08-21 Neurosearch As Kaliumkanal-modulatoren
KR20040106298A (ko) * 2002-03-21 2004-12-17 아나디스 리미티드 불안정한 생활성 물질 및 포유동물 초유를 포함한 조성물,제조 및 치료 방법
DE60336128D1 (de) * 2002-05-20 2011-04-07 Cedars Sinai Medical Ct Los Angeles Its durch modulation der methankonzentration im darm
US10066254B2 (en) 2002-05-20 2018-09-04 Cedars-Sinai Medical Center Diagnosis of constipation by analysis of methane concentration
US9072728B2 (en) * 2003-09-18 2015-07-07 Children's Medical Center Corporation Treatment of severe distal colitis
US20060013890A1 (en) * 2004-06-24 2006-01-19 Green Shawn J Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
US20070087002A1 (en) * 2005-10-14 2007-04-19 Green Shawn J Anticholesterol immunoglobulin to treat lipid raft diseases
KR101560844B1 (ko) * 2007-06-04 2015-10-15 벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 트라이-아릴계 화합물 및 이를 포함하는 조성물
WO2009027292A1 (en) 2007-08-24 2009-03-05 Neurosearch A/S Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
KR101345860B1 (ko) 2011-10-25 2013-12-30 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 혈관질환 치료용 조성물
CN111494375A (zh) 2013-03-15 2020-08-07 雪松-西奈医学中心 由产甲烷菌引起或与之相关的疾病和病状的诊断、选择和治疗方法
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
CN103266281B (zh) * 2013-05-24 2015-02-04 无锡鑫常钢管有限责任公司 一种超级双相不锈钢管及其生产工艺
EA201690938A1 (ru) 2013-11-05 2016-11-30 Бен-Гурион Юниверсити Оф Дзе Негев Рисерч Энд Дивелопмент Оторити Соединения для лечения диабета и осложнений, возникающих из-за этого заболевания
AU2015301596B2 (en) 2014-08-13 2020-04-16 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
US10736871B2 (en) 2015-04-01 2020-08-11 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
KR20210119425A (ko) * 2019-01-16 2021-10-05 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 티로신 키나제 억제제-유도된 설사를 치료하는 방법
JP6664637B1 (ja) * 2019-08-08 2020-03-13 株式会社 レオロジー機能食品研究所 ストレス低下用及び／又は体重回復用経口組成物、並びにプラズマローゲン含有組成物の製造方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US307874A (en) * 1884-11-11 Bessemer converter
US3655882A (en) * 1968-08-26 1972-04-11 Staley Mfg Co A E Stable dietary supplement for new born pigs
US3965112A (en) * 1971-01-11 1976-06-22 John Wyeth & Brother Limited Imidazoline derivatives
CA1007568A (en) * 1973-12-13 1977-03-29 Canada Packers Limited Bovine immunoglobulin isolation process
US3917615A (en) * 1974-04-01 1975-11-04 Searle & Co 1,1-Diaryl-1-oxadiazol-alkylamines
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
US4284829A (en) * 1977-09-13 1981-08-18 Pfizer Inc. Hydroxyalkyl and oxoalkyl substituted phenols as analgesics and sedatives
US4806685A (en) 1985-08-05 1989-02-21 Gyogyszerkutato Inteezet/Pharmaceutical Research Institute 1,1,2-triphenylpropane and -propene derivatives
JPS62163662A (ja) * 1986-01-11 1987-07-20 Nippon Nousan Kogyo Kk 犬猫用ペツトフ−ド
KR970009887B1 (ko) 1987-12-24 1997-06-19 존 에이취. 뉴만 심방의 나트륨이뇨성 펩티드의 선형유사체
AU629559B2 (en) * 1988-08-04 1992-10-08 Thomas Julius Borody Oral antibody therapy for patients with lowered immune response and composition therefor
AU5254790A (en) * 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
CA2081388A1 (en) * 1990-04-09 1991-10-10 Medicis Corporation Antidiarrheal composition and method
DE4130689A1 (de) * 1991-09-14 1993-03-18 Biotest Pharma Gmbh Verfahren zur herstellung eines leicht loeslichen getrockneten immunglobulin-praeparats aus kolostralmilch
US5430062A (en) 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5387600A (en) 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
US5512591A (en) 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
US5439086A (en) * 1993-12-10 1995-08-08 Oceaneering International, Inc. Mechanical clutch
FR2715068B1 (fr) * 1994-01-17 1996-04-19 Paul Vidal Procédé permettant de recueillir des doses de sérocolostrum bovin destinées à être administrées par voie orale à des veaux nouveau-nés ainsi que dispositif permettant la mise en Óoeuvre de ce procédé.
US5650425A (en) 1994-04-04 1997-07-22 Pharmos Corporation Permanently ionic derivatives of steroid hormones and their antagonists
AU2880595A (en) 1994-07-06 1996-01-25 Bo Arne Hofmann Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
WO1997034589A1 (en) 1996-03-20 1997-09-25 President And Fellows Of Harvard College Triaryl methane compounds for sickle cell disease
EP0781128B1 (en) * 1994-09-16 2005-11-23 Children's Medical Center Corporation Clotrimazole metabolites in the treatment of sickle cell disease
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
EP1052990A2 (en) 1997-11-14 2000-11-22 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction

Also Published As

Publication number Publication date
JP2009007368A (ja) 2009-01-15
JP2000506895A (ja) 2000-06-06
ES2199358T3 (es) 2004-02-16
US5889038A (en) 1999-03-30
WO1997034599A3 (en) 1998-02-12
ATE245981T1 (de) 2003-08-15
WO1997034599A2 (en) 1997-09-25
EP0910376A2 (en) 1999-04-28
DK0910376T3 (da) 2003-11-17
US6495567B1 (en) 2002-12-17
DE69723843T2 (de) 2004-03-04
DE69723843D1 (de) 2003-09-04
US20030119784A1 (en) 2003-06-26
EP0910376B1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
DK0910376T3 (da) Anvendelse af clotrimazol og beslægtede forbindelser i behandlingen af diarré
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
CY1107484T1 (el) Παραγωγα γκελνταναμυκινης χρησιμοποιουμενα για τη θεραπεια καρκινου
DE59508891D1 (de) Hautpflegemittel
BR9714164B1 (pt) combinação de herbicida-protetor; agente e processo para proteção de plantas; derivados de ácido 2-fluoracrìlico, seu emprego e processo para prepará-los.
BR9913752B1 (pt) uso de um produto para proteÇço de tecidos, e, processo para tratamento de tecidos.
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ES2096577T3 (es) Utilizacion del cetoconazol y un retinoide para el tratamiento del acne vulgar.
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE3778008D1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
AU5170499A (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
HU9700598D0 (en) Process for profilacting and treating pancreatitis
DE69003937D1 (de) Mittel für die diagnose und die behandlung der melanomen, halogenierte, aromatische derivate, verwendbar als solche mittel und ihre herstellung.
BR9612483A (pt) Utilização de um inibidor de eca ou de um sal fisiologicamente aceitável do mesmo preparação farmacêutica medicamento e processo para a profilaxia ou tratamento de sintomas dispépticos de origem desconhecida em mamíferos
PL315681A1 (en) Neuroprotective chromane compounds
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
FR2827518B1 (fr) Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
BR9909971A (pt) Uso de um composto, processo para tratamento ou prevenção da sìndrome de intestinos irritáveis, e, composição farmacêutica para o tratamento da sìndrome dos intestinos irritáveis
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
GR3033061T3 (en) Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ZA843489B (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system